JPMorgan Starts ResMed (RMD) at Neutral
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $209.63 +4.24%
Rating Summary:
13 Buy, 10 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
13 Buy, 10 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
JPMorgan initiated coverage on ResMed (NYSE: RMD) with a Neutral rating and a price target of $64.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $64.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts Kanzhun Ltd (2076:HK) at Overweight
- Morgan Stanley Resumes OMV AG (OMV:AV) (OMVKY) at Equalweight
- JPMorgan Upgrades Nanya Technology Corp (2408:TT) to Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
